Market Overview

Valeant Closes Purchase of Medicis; Announces Data of 2013 Guidance Call

Share:
Related VRX
How Big Pharma Uses Charity Programs To Cover Drug Price Hikes
Acorda Dips 2%, Company Says It Will Discontinue Development Of Nasal Spray
Valeant: Huge Risk/Reward (Seeking Alpha)

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) today announced the completion of its acquisition of Medicis Pharmaceutical Corporation ("Medicis") following the approval of the transaction by stockholders of Medicis at the special meeting held on December 7, 2012. Valeant acquired all of the common stock of Medicis outstanding at the time of the completion of the acquisition, for $44.00 per share in cash.

In addition, Valeant will be hosting a conference call and a live Internet webcast along with a slide presentation on Friday, January 4, 2013 at 8:00 a.m. EST (5:00 a.m. PST) to announce 2013 financial guidance.

The dial-in number to participate on this call is (877) 295-5743, confirmation code 80343257.  International callers should dial (973) 200-3961, confirmation code 80343257. A replay will be available approximately two hours following the conclusion of the conference call to Friday, January 11, 2013, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 80343257.

Posted-In: News Guidance M&A

 

Related Articles (VRX)

View Comments and Join the Discussion!